Quest Diagnostics Incorporated

NYSE:DGX Stock Report

Market Cap: US$18.3b

Quest Diagnostics Management

Management criteria checks 4/4

Quest Diagnostics' CEO is Jim Davis, appointed in Nov 2022, has a tenure of 2.25 years. total yearly compensation is $12.67M, comprised of 9.3% salary and 90.7% bonuses, including company stock and options. directly owns 0.067% of the company’s shares, worth $12.34M. The average tenure of the management team and the board of directors is 2.6 years and 5.5 years respectively.

Key information

Jim Davis

Chief executive officer

US$12.7m

Total compensation

CEO salary percentage9.3%
CEO tenure2.3yrs
CEO ownership0.07%
Management average tenure2.6yrs
Board average tenure5.5yrs

Recent management updates

Recent updates

Quest Diagnostics Incorporated (NYSE:DGX) Yearly Results: Here's What Analysts Are Forecasting For This Year

Feb 02
Quest Diagnostics Incorporated (NYSE:DGX) Yearly Results: Here's What Analysts Are Forecasting For This Year

Quest Diagnostics: Good Growth Prospects, But Little To No Upside Left At Current Valuation

Jan 28

Quest Diagnostics Incorporated (NYSE:DGX) Could Be Riskier Than It Looks

Jan 26
Quest Diagnostics Incorporated (NYSE:DGX) Could Be Riskier Than It Looks

Is Quest Diagnostics (NYSE:DGX) A Risky Investment?

Dec 18
Is Quest Diagnostics (NYSE:DGX) A Risky Investment?

Is Now The Time To Look At Buying Quest Diagnostics Incorporated (NYSE:DGX)?

Nov 30
Is Now The Time To Look At Buying Quest Diagnostics Incorporated (NYSE:DGX)?

Investors Met With Slowing Returns on Capital At Quest Diagnostics (NYSE:DGX)

Nov 12
Investors Met With Slowing Returns on Capital At Quest Diagnostics (NYSE:DGX)

Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Oct 25
Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat

Oct 24

Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E

Oct 23
Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E

Quest Diagnostics: The Better Half Of An Emerging Healthcare Duopoly

Oct 15

These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well

Aug 30
These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well

Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?

Aug 12
Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?

Quest Diagnostics: Beat Down After Beating Q2 Estimates

Jul 28

The Price Is Right For Quest Diagnostics Incorporated (NYSE:DGX)

Jul 12
The Price Is Right For Quest Diagnostics Incorporated (NYSE:DGX)

Quest Diagnostics: On A Quest For Growth

Jul 12

Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns

May 14
Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns

Quest Diagnostics: Let's Keep Waiting

May 08

Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts

Apr 26
Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts

We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt

Apr 23
We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt

Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares

Apr 02
Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares

Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year

Mar 15
Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year

Quest Diagnostics: Post-COVID Normalization Pretty Much Done

Feb 05

Quest Diagnostics: Market Overreaction Creates Investment Opportunity

Dec 08

Quest Diagnostics: Moving Past Covid

Oct 25

Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues

Aug 15

CEO Compensation Analysis

How has Jim Davis's remuneration changed compared to Quest Diagnostics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024n/an/a

US$866m

Sep 30 2024n/an/a

US$838m

Jun 30 2024n/an/a

US$836m

Mar 31 2024n/an/a

US$842m

Dec 31 2023US$13mUS$1m

US$850m

Sep 30 2023n/an/a

US$759m

Jun 30 2023n/an/a

US$790m

Mar 31 2023n/an/a

US$789m

Dec 31 2022US$12mUS$806k

US$942m

Sep 30 2022n/an/a

US$1b

Jun 30 2022n/an/a

US$1b

Mar 31 2022n/an/a

US$2b

Dec 31 2021US$4mUS$625k

US$2b

Sep 30 2021n/an/a

US$2b

Jun 30 2021n/an/a

US$2b

Mar 31 2021n/an/a

US$2b

Dec 31 2020US$4mUS$577k

US$1b

Sep 30 2020n/an/a

US$1b

Jun 30 2020n/an/a

US$749m

Mar 31 2020n/an/a

US$771m

Dec 31 2019US$3mUS$590k

US$835m

Sep 30 2019n/an/a

US$709m

Jun 30 2019n/an/a

US$707m

Mar 31 2019n/an/a

US$720m

Dec 31 2018US$3mUS$590k

US$733m

Compensation vs Market: Jim's total compensation ($USD12.67M) is about average for companies of similar size in the US market ($USD12.46M).

Compensation vs Earnings: Jim's compensation has been consistent with company performance over the past year.


CEO

Jim Davis (61 yo)

2.3yrs

Tenure

US$12,673,834

Compensation

Mr. James E. Davis, also known as Jim, serves as Chief Executive Officer and President at Quest Diagnostics Incorporated since November 1, 2022 and serves as its Director since November 2022. He served as...


Leadership Team

NamePositionTenureCompensationOwnership
James Davis
Chairman2.3yrsUS$12.67m0.067%
$ 12.3m
Sam Samad
Executive VP & CFO2.6yrsUS$3.98m0.016%
$ 2.9m
Michael Prevoznik
Senior VP & General Counsel25.5yrsUS$2.25m0.040%
$ 7.3m
Catherine Doherty
Executive Vice President of Regional Businessesno dataUS$3.16m0.066%
$ 12.0m
Karthik Kuppusamy
Senior Vice President of Clinical Solutions2.5yrsUS$2.02m0.011%
$ 1.9m
Michael Deppe
Senior VP5.8yrsno data0.032%
$ 5.9m
Murali Balakumar
Senior VPless than a yearno datano data
Shawn Bevec
Vice President of Investor Relationsno datano datano data
Kristin Wallace
Senior VP & Chief Compliance Officer2.3yrsno datano data
Garry Clark
Senior VP and Chief Marketing & Communications Officerno datano datano data
Cecilia McKenney
Senior VP & Chief Human Resources Officer7yrsno datano data
Dermot Shorten
Senior Vice President of Strategy9yrsno datano data

2.6yrs

Average Tenure

61yo

Average Age

Experienced Management: DGX's management team is considered experienced (2.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
James Davis
Chairman2.3yrsUS$12.67m0.067%
$ 12.3m
Timothy Main
Independent Director11.1yrsUS$315.44k0.023%
$ 4.1m
Robert Carter
Directorless than a yearno datano data
Timothy Ring
Lead Independent Director13.2yrsUS$345.94kno data
Gary Pfeiffer
Independent Director20.2yrsUS$342.12kno data
Denise Morrison
Independent Director6yrsUS$312.33k0.0026%
$ 472.2k
Vicky Gregg
Independent Director10.6yrsUS$315.73k0.016%
$ 3.0m
Wright Lassiter
Independent Director4.9yrsUS$300.44kno data
Tracey Doi
Independent Director3.5yrsUS$300.44kno data
Luis Diaz
Independent Director1.8yrsUS$280.41kno data

5.5yrs

Average Tenure

65yo

Average Age

Experienced Board: DGX's board of directors are considered experienced (5.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 23:02
End of Day Share Price 2025/02/06 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Quest Diagnostics Incorporated is covered by 45 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Brian Kemp DolliverAvondale Partners
Eric ColdwellBaird